$HQY
HEALTHEQUITY, INC. Stock $hqy

$hqy Overview Financials Valuation SEC Filings Company Website

2015 Q2 Form 10-Q Financial Statement

#000142833615000015 Filed on June 11, 2015

Income Statement

Concept	2015 Q2	2014 Q2
Revenue	$29.85M	$20.23M
YoY Change	47.55%	38.34%
Cost Of Revenue	$11.94M	$8.772M
YoY Change	36.16%	25.94%
Gross Profit	$17.91M	$11.46M
YoY Change	56.26%	49.61%
Gross Profit Margin	59.99%	56.64%
Selling, General & Admin	$5.991M	$3.376M
YoY Change	77.46%	25.04%
% of Gross Profit	33.46%	29.46%
Research & Development	$3.524M	$2.186M
YoY Change	61.21%	28.59%
% of Gross Profit	19.68%	19.08%
Depreciation & Amortization	$1.750M	$1.251M
YoY Change	39.89%	25.1%
% of Gross Profit	9.77%	10.92%
Operating Expenses	$9.924M	$5.971M
YoY Change	66.2%	26.16%
Operating Profit	$7.982M	$5.488M
YoY Change	45.44%	87.56%
Interest Expense	$0.00	-$700.0K
YoY Change	-100.0%
% of Operating Profit	0.0%	-12.76%
Other Income/Expense, Net	-$105.0K	-$827.0K
YoY Change	-87.3%	727.0%
Pretax Income	$7.877M	$4.661M
YoY Change	69.0%	66.46%
Income Tax	$2.900M	$1.943M
% Of Pretax Income	36.82%	41.69%
Net Earnings	$4.977M	$2.718M
YoY Change	83.11%	55.31%
Net Earnings / Revenue	16.67%	13.43%
Basic Earnings Per Share	$0.09	$0.52
Diluted Earnings Per Share	$0.09	$0.08
COMMON SHARES
Basic Shares Outstanding	55.06M shares	7.367M shares
Diluted Shares Outstanding	57.77M shares	43.74M shares

Balance Sheet

Concept	2015 Q2	2014 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$114.9M	$14.00M
YoY Change	720.71%
Cash & Equivalents	$74.86M	$13.99M
Short-Term Investments	$40.00M
Other Short-Term Assets	$4.200M	$3.200M
YoY Change	31.25%
Inventory	$667.0K	$400.0K
Prepaid Expenses	$2.761M
Receivables	$10.48M	$6.100M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$130.3M	$23.60M
YoY Change	452.0%
LONG-TERM ASSETS
Property, Plant & Equipment	$3.079M	$2.200M
YoY Change	39.95%
Goodwill	$4.651M
YoY Change
Intangibles	$26.62M
YoY Change
Long-Term Investments	$300.0K
YoY Change
Other Assets	$662.0K
YoY Change
Total Long-Term Assets	$35.01M	$32.30M
YoY Change	8.39%
TOTAL ASSETS
Total Short-Term Assets	$130.3M	$23.60M
Total Long-Term Assets	$35.01M	$32.30M
Total Assets	$165.3M	$55.90M
YoY Change	195.67%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$990.0K	$700.0K
YoY Change	41.43%
Accrued Expenses	$2.153M	$4.100M
YoY Change	-47.49%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due		$0.00
YoY Change
Total Short-Term Liabilities	$5.184M	$5.800M
YoY Change	-10.62%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$500.0K	$400.0K
YoY Change	25.0%
Total Long-Term Liabilities	$5.530M	$400.0K
YoY Change	1282.5%
TOTAL LIABILITIES
Total Short-Term Liabilities	$5.184M	$5.800M
Total Long-Term Liabilities	$5.530M	$400.0K
Total Liabilities	$10.71M	$11.60M
YoY Change	-7.64%
SHAREHOLDERS EQUITY
Retained Earnings	-$8.027M
YoY Change
Common Stock	$6.000K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$154.6M	$44.30M
YoY Change
Total Liabilities & Shareholders Equity	$165.3M	$55.90M
YoY Change	195.67%

Cashflow Statement

Concept	2015 Q2	2014 Q2
OPERATING ACTIVITIES
Net Income	$4.977M	$2.718M
YoY Change	83.11%	55.31%
Depreciation, Depletion And Amortization	$1.750M	$1.251M
YoY Change	39.89%	25.1%
Cash From Operating Activities	$1.771M	$1.463M
YoY Change	21.05%	-52.81%
INVESTING ACTIVITIES
Capital Expenditures	$826.0K	$480.0K
YoY Change	72.08%	-148.0%
Acquisitions
YoY Change
Other Investing Activities	-$40.10M	$0.00
YoY Change
Cash From Investing Activities	-$42.34M	-$2.192M
YoY Change	1831.52%	119.2%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$4.424M	$802.0K
YoY Change	451.62%	-161.69%
NET CHANGE
Cash From Operating Activities	$1.771M	$1.463M
Cash From Investing Activities	-$42.34M	-$2.192M
Cash From Financing Activities	$4.424M	$802.0K
Net Change In Cash	-$36.14M	$73.00K
YoY Change	-49612.33%	-90.88%
FREE CASH FLOW
Cash From Operating Activities	$1.771M	$1.463M
Capital Expenditures	$826.0K	$480.0K
Free Cash Flow	$945.0K	$983.0K
YoY Change	-3.87%	-76.02%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2015Q2	dei	Amendment Flag AmendmentFlag	false
CY2015Q2	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--01-31
CY2015Q2	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2015Q2	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2016
CY2015Q2	dei	Document Period End Date DocumentPeriodEndDate	2015-04-30
CY2015Q2	dei	Document Type DocumentType	10-Q
CY2015Q2	dei	Entity Central Index Key EntityCentralIndexKey	0001428336
CY2015Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	56722533	shares
CY2015Q2	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2015Q2	dei	Entity Registrant Name EntityRegistrantName	HEALTHEQUITY INC
CY2014Q2	hqy	Amortizationof Acquired Intangible AmortizationofAcquiredIntangible	409000	USD
CY2015Q2	hqy	Amortizationof Acquired Intangible AmortizationofAcquiredIntangible	409000	USD
CY2015Q1	hqy	Cash Cash Equivalentsand Shortterm Investments Fair Value Disclosure CashCashEquivalentsandShorttermInvestmentsFairValueDisclosure	111005000	USD
CY2015Q2	hqy	Cash Cash Equivalentsand Shortterm Investments Fair Value Disclosure CashCashEquivalentsandShorttermInvestmentsFairValueDisclosure	114901000	USD
CY2014Q2	hqy	Common Stock Warrants Exercised CommonStockWarrantsExercised	75000	USD
CY2015Q2	hqy	Common Stock Warrants Exercised CommonStockWarrantsExercised	0	USD
CY2014Q2	hqy	Cost Of Services Card Costs CostOfServicesCardCosts	1405000	USD
CY2015Q2	hqy	Cost Of Services Card Costs CostOfServicesCardCosts	2102000	USD
CY2014Q2	hqy	Cost Of Services Custodial Costs CostOfServicesCustodialCosts	938000	USD
CY2015Q2	hqy	Cost Of Services Custodial Costs CostOfServicesCustodialCosts	1423000	USD
CY2014Q2	hqy	Dilutive Securities Effecton Basic Earnings Per Share Dilutive Convertible Securities Other Adjustment DilutiveSecuritiesEffectonBasicEarningsPerShareDilutiveConvertibleSecuritiesOtherAdjustment	2258000	USD
CY2015Q2	hqy	Dilutive Securities Effecton Basic Earnings Per Share Dilutive Convertible Securities Other Adjustment DilutiveSecuritiesEffectonBasicEarningsPerShareDilutiveConvertibleSecuritiesOtherAdjustment	0	USD
CY2014Q2	hqy	Dilutive Securities Effecton Basic Earnings Per Share Dilutive Convertible Securities Revaluation Adjustment DilutiveSecuritiesEffectonBasicEarningsPerShareDilutiveConvertibleSecuritiesRevaluationAdjustment	735000	USD
CY2015Q2	hqy	Dilutive Securities Effecton Basic Earnings Per Share Dilutive Convertible Securities Revaluation Adjustment DilutiveSecuritiesEffectonBasicEarningsPerShareDilutiveConvertibleSecuritiesRevaluationAdjustment	0	USD
CY2014Q2	hqy	Loss On Revaluation Of Warrants LossOnRevaluationOfWarrants	735000	USD
CY2015Q2	hqy	Loss On Revaluation Of Warrants LossOnRevaluationOfWarrants	0	USD
CY2014Q2	hqy	Other Expenses Agreements OtherExpensesAgreements	53000	USD
CY2015Q2	hqy	Other Expenses Agreements OtherExpensesAgreements	60000	USD
CY2014Q2	hqy	Revaluation Of Redeemable Convertible Preferred Stock Derivative RevaluationOfRedeemableConvertiblePreferredStockDerivative	735000	USD
CY2015Q2	hqy	Revaluation Of Redeemable Convertible Preferred Stock Derivative RevaluationOfRedeemableConvertiblePreferredStockDerivative	0	USD
CY2015Q2	hqy	Sharebased Compensation Shares Authorizedunder Stock Option Plans Exercise Price Range Lower Range Limit Exercised SharebasedCompensationSharesAuthorizedunderStockOptionPlansExercisePriceRangeLowerRangeLimitExercised	0.10
CY2015Q2	hqy	Sharebased Compensation Shares Authorizedunder Stock Option Plans Exercise Price Range Lower Range Limit Forfeited SharebasedCompensationSharesAuthorizedunderStockOptionPlansExercisePriceRangeLowerRangeLimitForfeited	0.80
CY2015Q1	hqy	Sharebased Compensation Shares Authorizedunder Stock Option Plans Exercise Price Range Lower Range Limit Outstanding SharebasedCompensationSharesAuthorizedunderStockOptionPlansExercisePriceRangeLowerRangeLimitOutstanding	1.10
CY2015Q2	hqy	Sharebased Compensation Shares Authorizedunder Stock Option Plans Exercise Price Range Lower Range Limit Outstanding SharebasedCompensationSharesAuthorizedunderStockOptionPlansExercisePriceRangeLowerRangeLimitOutstanding	1.10
CY2015Q2	hqy	Sharebased Compensation Shares Authorizedunder Stock Option Plans Exercise Price Range Upper Range Limit Exercised SharebasedCompensationSharesAuthorizedunderStockOptionPlansExercisePriceRangeUpperRangeLimitExercised	3.50
CY2015Q2	hqy	Sharebased Compensation Shares Authorizedunder Stock Option Plans Exercise Price Range Upper Range Limit Forfeited SharebasedCompensationSharesAuthorizedunderStockOptionPlansExercisePriceRangeUpperRangeLimitForfeited	25.45
CY2015Q1	hqy	Sharebased Compensation Shares Authorizedunder Stock Option Plans Exercise Price Range Upper Range Limit Outstanding SharebasedCompensationSharesAuthorizedunderStockOptionPlansExercisePriceRangeUpperRangeLimitOutstanding	25.45
CY2015Q2	hqy	Sharebased Compensation Shares Authorizedunder Stock Option Plans Exercise Price Range Upper Range Limit Outstanding SharebasedCompensationSharesAuthorizedunderStockOptionPlansExercisePriceRangeUpperRangeLimitOutstanding	25.45
CY2015Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	1303000	USD
CY2015Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	990000	USD
CY2015Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	9054000	USD
CY2015Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	10479000	USD
CY2015Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2227000	USD
CY2015Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2153000	USD
CY2015Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	3259000	USD
CY2015Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	3583000	USD
CY2015Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	0	USD
CY2015Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-22000	USD
CY2015Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	157094000	USD
CY2015Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	162611000	USD
CY2014Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	65000	USD
CY2015Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1094000	USD
CY2015Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	40000	USD
CY2015Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	39000	USD
CY2014Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1000000	USD
CY2015Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1400000	USD
CY2014Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	145000	shares
CY2015Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	679000	shares
CY2015Q1	us-gaap	Assets Assets	158769000	USD
CY2015Q2	us-gaap	Assets Assets	165282000	USD
CY2015Q1	us-gaap	Assets Current AssetsCurrent	124719000	USD
CY2015Q2	us-gaap	Assets Current AssetsCurrent	130272000	USD
CY2015Q1	us-gaap	Available For Sale Securities AvailableForSaleSecurities	0	USD
CY2015Q2	us-gaap	Available For Sale Securities AvailableForSaleSecurities	40040000	USD
CY2015Q1	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	0	USD
CY2015Q2	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	0	USD
CY2015Q1	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	0	USD
CY2015Q2	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	22000	USD
CY2015Q1	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	0	USD
CY2015Q2	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost	15035000	USD
CY2015Q2	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	15018000	USD
CY2015Q2	us-gaap	Available For Sale Securities Debt Maturities Single Maturity Date AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate	40040000	USD
CY2015Q2	us-gaap	Available For Sale Securities Debt Maturities Single Maturity Date Amortized Cost Basis AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis	40062000	USD
CY2015Q2	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	25027000	USD
CY2015Q2	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	25022000	USD
CY2014Q2	us-gaap	Capitalized Computer Software Additions CapitalizedComputerSoftwareAdditions	1100000	USD
CY2015Q2	us-gaap	Capitalized Computer Software Additions CapitalizedComputerSoftwareAdditions	1200000	USD
CY2014Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	13917000	USD
CY2014Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	13990000	USD
CY2015Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	111005000	USD
CY2015Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	74861000	USD
CY2015Q1	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	111005000	USD
CY2015Q2	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	74861000	USD
CY2014Q2	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	73000	USD
CY2015Q2	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-36144000	USD
CY2015Q1	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	111005000	USD
CY2015Q2	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	114923000	USD
CY2015Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2015Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2015Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2015Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2015Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	900000000	shares
CY2015Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	900000000	shares
CY2015Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	54754000	shares
CY2015Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	55308000	shares
CY2015Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	54754000	shares
CY2015Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	55308000	shares
CY2015Q1	us-gaap	Common Stock Value CommonStockValue	5000	USD
CY2015Q2	us-gaap	Common Stock Value CommonStockValue	6000	USD
CY2014Q2	us-gaap	Convertible Preferred Dividends Net Of Tax ConvertiblePreferredDividendsNetOfTax	-4021000	USD
CY2015Q2	us-gaap	Convertible Preferred Dividends Net Of Tax ConvertiblePreferredDividendsNetOfTax	0	USD
CY2014Q2	us-gaap	Cost Of Services CostOfServices	8772000	USD
CY2015Q2	us-gaap	Cost Of Services CostOfServices	11944000	USD
CY2014Q2	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	952000	USD
CY2015Q2	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-2000	USD
CY2015Q1	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	488000	USD
CY2015Q2	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	477000	USD
CY2015Q1	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	20000	USD
CY2015Q2	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	20000	USD
CY2015Q1	us-gaap	Deferred Tax Assets Liabilities Net Current DeferredTaxAssetsLiabilitiesNetCurrent	1764000	USD
CY2015Q2	us-gaap	Deferred Tax Assets Liabilities Net Current DeferredTaxAssetsLiabilitiesNetCurrent	1464000	USD
CY2015Q1	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	5355000	USD
CY2015Q2	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	5053000	USD
CY2014Q2	us-gaap	Depreciation Depreciation	239000	USD
CY2015Q2	us-gaap	Depreciation Depreciation	324000	USD
CY2014Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1251000	USD
CY2015Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1750000	USD
CY2014Q2	us-gaap	Dilutive Securities Effect On Basic Earnings Per Share Other DilutiveSecuritiesEffectOnBasicEarningsPerShareOther	632000	USD
CY2015Q2	us-gaap	Dilutive Securities Effect On Basic Earnings Per Share Other DilutiveSecuritiesEffectOnBasicEarningsPerShareOther	0	USD
CY2014Q2	us-gaap	Dividends Preferred Stock DividendsPreferredStock	169000	USD
CY2015Q2	us-gaap	Dividends Preferred Stock DividendsPreferredStock	0	USD
CY2014Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.52
CY2015Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.09
CY2014Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.08
CY2015Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.09
CY2014Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.417
CY2015Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.368
CY2014Q2	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.017
CY2015Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	5301000	USD
CY2015Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	2041000	USD
CY2015Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y11M
CY2015Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	14300000	USD
CY2014Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Out Of Level3 FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3	6917000	USD
CY2015Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Out Of Level3 FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3	0	USD
CY2014Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	735000	USD
CY2015Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	0	USD
CY2014Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	6182000	USD
CY2014Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	0	USD
CY2015Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	0	USD
CY2015Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	0	USD
CY2014Q2	us-gaap	Fees And Commissions Credit And Debit Cards FeesAndCommissionsCreditAndDebitCards	4298000	USD
CY2015Q2	us-gaap	Fees And Commissions Credit And Debit Cards FeesAndCommissionsCreditAndDebitCards	6817000	USD
CY2015Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	13185000	USD
CY2015Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	14611000	USD
CY2015Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	39726000	USD
CY2015Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	41229000	USD
CY2015Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	26541000	USD
CY2015Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	26618000	USD
CY2014Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1143000	USD
CY2015Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3158000	USD
CY2015Q1	us-gaap	Goodwill Goodwill	4651000	USD
CY2015Q2	us-gaap	Goodwill Goodwill	4651000	USD
CY2014Q2	us-gaap	Goodwill Period Increase Decrease GoodwillPeriodIncreaseDecrease	0	USD
CY2015Q2	us-gaap	Goodwill Period Increase Decrease GoodwillPeriodIncreaseDecrease	0	USD
CY2014Q2	us-gaap	Gross Profit GrossProfit	11459000	USD
CY2015Q2	us-gaap	Gross Profit GrossProfit	17906000	USD
CY2014Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	4661000	USD
CY2015Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	7877000	USD
CY2014Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1943000	USD
CY2015Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2900000	USD
CY2014Q2	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-1620000	USD
CY2015Q2	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-340000	USD
CY2014Q2	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	345000	USD
CY2015Q2	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1425000	USD
CY2014Q2	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	803000	USD
CY2015Q2	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	0	USD
CY2014Q2	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-572000	USD
CY2015Q2	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-99000	USD
CY2014Q2	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-2368000	USD
CY2015Q2	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-3260000	USD
CY2014Q2	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	5000	USD
CY2015Q2	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	42000	USD
CY2014Q2	us-gaap	Increase Decrease In Other Deferred Liability IncreaseDecreaseInOtherDeferredLiability	29000	USD
CY2015Q2	us-gaap	Increase Decrease In Other Deferred Liability IncreaseDecreaseInOtherDeferredLiability	-11000	USD
CY2014Q2	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	180000	USD
CY2015Q2	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	871000	USD
CY2014Q2	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	2119000	shares
CY2015Q2	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	0	shares
CY2014Q2	us-gaap	Incremental Common Shares Attributable To Conversion Of Preferred Stock IncrementalCommonSharesAttributableToConversionOfPreferredStock	32468000	shares
CY2015Q2	us-gaap	Incremental Common Shares Attributable To Conversion Of Preferred Stock IncrementalCommonSharesAttributableToConversionOfPreferredStock	0	shares
CY2014Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1782000	shares
CY2015Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	2707000	shares
CY2015Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	26541000	USD
CY2015Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	26618000	USD
CY2015Q1	us-gaap	Inventory Net InventoryNet	625000	USD
CY2015Q2	us-gaap	Inventory Net InventoryNet	667000	USD
CY2014Q2	us-gaap	Investment Advisory Management And Administrative Fees InvestmentAdvisoryManagementAndAdministrativeFees	5427000	USD
CY2015Q2	us-gaap	Investment Advisory Management And Administrative Fees InvestmentAdvisoryManagementAndAdministrativeFees	8419000	USD
CY2014Q2	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	276000	USD
CY2015Q2	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	464000	USD
CY2015Q1	us-gaap	Liabilities Liabilities	14674000	USD
CY2015Q2	us-gaap	Liabilities Liabilities	10714000	USD
CY2015Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	158769000	USD
CY2015Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	165282000	USD
CY2015Q1	us-gaap	Liabilities Current LiabilitiesCurrent	8831000	USD
CY2015Q2	us-gaap	Liabilities Current LiabilitiesCurrent	5184000	USD
CY2015Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	5843000	USD
CY2015Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	5530000	USD
CY2014Q2	us-gaap	Membership Dues Revenue On Going MembershipDuesRevenueOnGoing	10388000	USD
CY2015Q2	us-gaap	Membership Dues Revenue On Going MembershipDuesRevenueOnGoing	14397000	USD
CY2014Q2	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	802000	USD
CY2015Q2	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	4424000	USD
CY2014Q2	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2192000	USD
CY2015Q2	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-42339000	USD
CY2014Q2	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1463000	USD
CY2015Q2	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1771000	USD
CY2014Q2	us-gaap	Net Income Loss NetIncomeLoss	2718000	USD
CY2015Q2	us-gaap	Net Income Loss NetIncomeLoss	4977000	USD
CY2014Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	3849000	USD
CY2015Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	4977000	USD
CY2014Q2	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	3453000	USD
CY2015Q2	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	4977000	USD
CY2014Q2	us-gaap	Operating Expenses OperatingExpenses	5971000	USD
CY2015Q2	us-gaap	Operating Expenses OperatingExpenses	9924000	USD
CY2014Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	5488000	USD
CY2015Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	7982000	USD
CY2015Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	281000	USD
CY2015Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	662000	USD
CY2014Q2	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	0	USD
CY2015Q2	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	-22000	USD
CY2014Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	2718000	USD
CY2015Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	4955000	USD
CY2014Q2	us-gaap	Other Cost Of Services OtherCostOfServices	1000	USD
CY2015Q2	us-gaap	Other Cost Of Services OtherCostOfServices	30000	USD
CY2014Q2	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	92000	USD
CY2015Q2	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	105000	USD
CY2014Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-827000	USD
CY2015Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-105000	USD
CY2014Q2	us-gaap	Other Sales Revenue Net OtherSalesRevenueNet	118000	USD
CY2015Q2	us-gaap	Other Sales Revenue Net OtherSalesRevenueNet	217000	USD
CY2014Q2	us-gaap	Payments For Software PaymentsForSoftware	1712000	USD
CY2015Q2	us-gaap	Payments For Software PaymentsForSoftware	1451000	USD
CY2014Q2	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	-154000	USD
CY2015Q2	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	-3931000	USD
CY2014Q2	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	0	USD
CY2015Q2	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	40062000	USD
CY2014Q2	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	480000	USD
CY2015Q2	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	826000	USD
CY2014Q2	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	632000	USD
CY2015Q2	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	0	USD
CY2015Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2015Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2015Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	100000000	shares
CY2015Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	100000000	shares
CY2015Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2015Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2015Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2015Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2015Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2015Q2	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2015Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	2271000	USD
CY2015Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	2761000	USD
CY2014Q2	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	251000	USD
CY2015Q2	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	493000	USD
CY2014Q2	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	397000	USD
CY2015Q2	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	0	USD
CY2015Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	5836000	USD
CY2015Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	6662000	USD
CY2015Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2577000	USD
CY2015Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3079000	USD
CY2014Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2186000	USD
CY2015Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3524000	USD
CY2014Q2	us-gaap	Research And Development Expense Software Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost	789000	USD
CY2015Q2	us-gaap	Research And Development Expense Software Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost	1700000	USD
CY2015Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-13004000	USD
CY2015Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-8027000	USD
CY2014Q2	us-gaap	Revenues Revenues	20231000	USD
CY2015Q2	us-gaap	Revenues Revenues	29850000	USD
CY2014Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	2233000	USD
CY2015Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	2833000	USD
CY2014Q2	us-gaap	Service Management Costs ServiceManagementCosts	6428000	USD
CY2015Q2	us-gaap	Service Management Costs ServiceManagementCosts	8389000	USD
CY2014Q2	us-gaap	Share Based Compensation ShareBasedCompensation	65000	USD
CY2015Q2	us-gaap	Share Based Compensation ShareBasedCompensation	1094000	USD
CY2015Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2015Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.403
CY2015Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	1.10
CY2015Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	13.74
CY2015Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	16000	shares
CY2014Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2015Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	581000	shares
CY2015Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	100290000	USD
CY2015Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	122734000	USD
CY2015Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	6457000	shares
CY2015Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	6516000	shares
CY2015Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	5.27
CY2015Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	7.37
CY2015Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	120166000	USD
CY2015Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	3589000	shares
CY2015Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	6270000	shares
CY2015Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	7.04
CY2015Q2	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.97
CY2015Q2	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	25.39
CY2015Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	90098000	USD
CY2015Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P5Y3M22D
CY2015	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y10M17D
CY2015Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y0M22D
CY2015Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1	P6Y11M20D
CY2015Q2	us-gaap	Significant Change In Unrecognized Tax Benefits Is Reasonably Possible Amount Of Unrecorded Benefit SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit	-20000	USD
CY2015Q2	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	506000	shares
CY2015Q1	us-gaap	Stockholders Equity StockholdersEquity	144095000	USD
CY2015Q2	us-gaap	Stockholders Equity StockholdersEquity	154568000	USD
CY2014Q2	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	-4021000	USD
CY2015Q2	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	0	USD
CY2014Q2	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	2258000	USD
CY2015Q2	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	0	USD
CY2015Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	300000	USD
CY2015Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	332000	USD
CY2015Q2	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	250000	USD
CY2014Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	43736000	shares
CY2015Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	57770000	shares
CY2014Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	7367000	shares
CY2015Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	55063000	shares

Files In Submission

Name	View Source	Status
0001428336-15-000015-index-headers.html	Edgar Link	pending
0001428336-15-000015-index.html	Edgar Link	pending
0001428336-15-000015.txt	Edgar Link	pending
0001428336-15-000015-xbrl.zip	Edgar Link	pending
exhibit101-bgscenicpointof.htm	Edgar Link	pending
exhibit102-bgscenicpointof.htm	Edgar Link	pending
exhibit103-hqyxamendedandr.htm	Edgar Link	pending
exhibit3112015-04x30.htm	Edgar Link	pending
exhibit3122015-04x30.htm	Edgar Link	pending
exhibit3212015-04x30.htm	Edgar Link	pending
exhibit3222015-04x30.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
hqy-20150430.xml	Edgar Link	completed
hqy-20150430.xsd	Edgar Link	pending
hqy-20150430_cal.xml	Edgar Link	unprocessable
hqy-20150430_def.xml	Edgar Link	unprocessable
hqy-20150430_lab.xml	Edgar Link	unprocessable
hqy-20150430_pre.xml	Edgar Link	unprocessable
hqy-2015x04x3010q.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$HQY
HEALTHEQUITY, INC. Stock $hqy

2015 Q2 Form 10-Q Financial Statement

#000142833615000015 Filed on June 11, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$HQY HEALTHEQUITY, INC. Stock $hqy

2015 Q2 Form 10-Q Financial Statement

#000142833615000015 Filed on June 11, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$HQY
HEALTHEQUITY, INC. Stock $hqy